The clinical significance of rapid self-terminating ventricular tachycardia induced during electrophysiologic study was prospectively evaluated in three patient groups with clinical ventricular arrhythmias. Group A (11 patients) had inducible rapid self-terminating ventricular tachycardia only (mean cycle length 5250 ms and 110 heats in duration). In Group B (22 patients) induction of this arrhythmia was followed by the induction of sustained ventricular tachycardia. In Group C (82 patients) sustained ventricular tachycardia was induced without preceding rapid selfterminating ventricular tachycardia.
All clinical characteristics of Group B patients were similar to those of Group C patients but differed markedly from those of Group A patients. Compared with Group A patients, Group B patients had a lower left ventricular ejection fraction (32 f 13% versus 52 + 17%, p = 0.004j and a greater prevalence of coronary artery disease (82% versus O%, p < O.OOOl), structural heart disease and a history of clinical sustained ventrical arrhythmias.
Programmed ventricular stimulation is a useful technique in the evaluation of patients with ventricular tachyarrhythmias. The most widely accepted end point of ventricular stimulation has been the induction of sustained ventricular tachycardia similar in rate and configuration to the clinical arrhythmia (l-6). However, in patients whose clinical arrhythmia is rapid ventricular tachycardia or ventricular fibrillation, the induction of a sustained arrhythmia often results in a very fast, hemodynamically unstable rhythm, requiring cardioversion for termination (2,7-9).
Similarly, the induced self-terminating ventricular tachycardia differed in Group A and Group B patients. The arrhythmias in Group B patients were more often monomorphic, were more often induced with one or two extrastimuli and had a longer cycle length than those in Group A patients. In Group B patients, the electrophysiologic characteristics of the self-terminating and the sustained induced ventricular tachycardias were similar. Cardioversion was required in 50% of Group B patients compared with 27% of Group C patients (p = 0.038).
Thus, induction of rapid self-terminating ventricular tachycardia in patients with coronary artery disease reliably predicts subsequent induction of sustained ventricular tachycardia of similar rate and configuration. Use of rapid self-terminating ventricular tachycardia as an electrophy siologic study end point in patients with corormry artery disease and documented or suspected ventricular arrhythmias will substantially reduce the need for cardioversion.
(J Am Co11 Cardiol1989;13:385-90) Self-terminating ventricular tachycardia is often induced by programmed ventricular stimulation. The relation of this induced tachycardia to clinical and induced sustained ventricular arrhythmias is not clear. Although self-terminating ventricular tachycardia is often considered to be a nonspecific electrophysiologic finding (l-3,10-12), some investigators (13) (14) (15) (16) have found it to be of prognostic importance.
This study prospectively evaluated the significance of induced self-terminating ventricular tachycardia by examining the clinical and electrophysiologic characteristics of three cohorts of patients: those with a maximal response of induced rapid self-terminating ventricular tachycardia 110 beats in duration, those with induced rapid self-terminating ventricular tachycardia preceding sustained ventricular tachycardia and those with induced sustained ventricular tachycardia without preceding rapid self-terminating ventricular tachycardia. 
Methods
Study patients. Between January 1985 and June 1987, consecutive patients who underwent electrophysiologic study in the antiarrhythmic drug-free state for the evaluation of documented or suspected ventricular arrhythmias were prospectively enrolled in this study if they had 1) induced sustained ventricular tachycardia, or 2) induced rapid selfterminating ventricular tachycardia (mean cycle length 5250 ms and r 10 beats in duration). One-hundred fifteen patients were classified into three groups on the basis of their electrophysiologic study results. Group A (11 patients) had induced rapid self-terminating ventricular tachycardia as the maximal response despite protocol completion. Group B (22 patients) had induced rapid self-terminating ventricular tachycardia and subsequently developed sustained ventricular tachycardia with further stimulation. Group C (82 patients) had induced sustained ventricular tachycardia that was not preceded by induced rapid self-terminating ventricular tachycardia.
Indications for electrophysiologic study were 1) clinical sustained ventricular arrhythmias not associated with acute myocardial infarction, significant electrolyte abnormalities or unstable angina; 2) frequent ventricular ectopic activity or nonsustained ventricular tachycardia associated with presyncope or syncope; or 3) nonsustained ventricular tachycardia in patients with significant organic heart disease and reduced left ventricular function ( Table 1 ). The diagnosis of coronary artery disease was made by a documented history of myocardial infarction or by cardiac catheterization findings. The absence of coronary artery disease was determined by clinical history, normal coronary angiograms, a negative exercise thallium test or a negative exercise tolerance test.
Electrophysiologic study protocol. After the patients gave written informed consent, they underwent electrophysiologic studies in the postabsorptive state after discontinuation of antiarrhythmic medication for at least 5 half-lives. No patient had received amiodarone for at least 4 months. Our stimulation protocol has previously been reported in detail (17) . One, two and three ventricular premature extrastimuli were delivered during drive runs at cycle lengths of 600 and 400 ms. Stimulation was performed at the right ventricular apex and outflow tract. The stimulus strength was twice diastolic threshold, and the pulse width was 1 .O ms. The end point of the protocol was the induction of sustained ventricular tachycardia or all premature extrastimuli brought to refractoriness.
Definitions. For the purpose of this investigation, induced self-terminating ventricular tachycardia was defined as ventricular tachycardia with well defined surface and endocardial electrograms with a mean cycle length 5250 ms and a duration 2 10 beats. Induced self-terminating ventricular tachycardias that did not meet these rate and duration criteria were not analyzed.
Induced sustained ventricular tachycardia
was dejned as ventricular tachycardia that lasted 230 s or required intervention for termination because of significant hemodynamic compromise. Ventricular fibrillation was defined as a totally disorganized rhythm without well defined surface QRS complexes.
Analysis of ventricular tachycardia. Ventricular tachycardia configuration was analyzed in a blinded fashion by three electrophysiologists. Monomorphic ventricular tachycardia had a uniform QRS in the monitored leads (I, aVF, V,, V,) after the first three beats of ventricular tachycardia. Polymorphic ventricular tachycardia had a change in axis of >45" or a change in QRS amplitude of >50% in any plane.
Equilibrium radionuclide angiograpby. This procedure was performed as previously described (18) . Radionuclide angiograms were analyzed for left ventricular ejection fraction and the presence of left ventricular aneurysm without knowledge of clinical history or electrophysiologic study results.
Statistics. Data were analyzed by Fisher's exact test and Student's t test (two-tailed) with use of the CLINFO computer resource. Comparisons were made between Group A and Group B and between Group B and Group C. Significance is defined as p < 0.05, and data are expressed as mean " SD.
Results
Clinical characteristics (Table 2) . Patients whose induced sustained ventricular tachycardia was preceded by induced self-terminating ventricular tachycardia (Group B) and patients who had only induced sustained ventricular tachycardia (Group C) during electrophysiologic study were remarkably similar in all clinical characteristics. In contrast, Group B patients differed distinctly from those patients with induced self-terminating ventricular tachycardia as the maximal response (Group A). Although no Group A patient had a history of myocardial infarction or coronary artery disease, 82% of Group B patients had coronary artery disease (p < 0.0001) and 77% had a history of myocardial infarction (p < 0.0001).
All Group B patients had structural heart disease, whereas 36% of Group A patients had a normal heart (p = When the clinical characteristics of all patients with induced rapid self-terminating ventricular tachycardia (Groups A and B) were examined, all I8 patients with coronary artery disease but only 4 (27%) of the 15 patients without coronary artery disease had sustained ventricular tachycardia after the induction of self-terminating ventricular tachycardia (p < 0.0001). This occurred in 14 (88%) of the I6 patients with a history of clinical sustained ventricular arrhythmias and 8 (47%) of the I7 patients without clinical sustained ventricular arrhythmias (p = 0.03).
Electrophysiologic characteristics of induced selfterminating ventricular tachycardia in Group A and Group B patients (Table 3 ). The electrophysiologic characteristics of the induced self-terminating ventricular tachycardia in (Table 4 ). The electrophysiologic characteristics of both the induced self-terminating and the sustained ventricular tachycardias in Group B patients were similar. Specifically, the mean cycle length of the induced selfterminating and induced sustained ventricular tachycardias (226 t 16 versus 226 t 34 ms, p = NS) were similar, and 55% of both induced self-terminating and sustained ventricular tachycardias were monomorphic. When the morpho- Tables 2 and 3. logic features of the induced self-terminating ventricular tachycardias and that of the induced sustained ventricular tachycardias were compared in a given patient, 82% of the arrhythmias were of similar configuration. Electrophysiologic characteristics of induced sustained ventricular tachycardia in Group B and Group C patients ( Table  5 ). The mean and minimal induced sustained ventricular tachycardia cycle lengths were shorter in Group B patients than in Group C patients. Although 51% of Group C patients had the sustained arrhythmias induced with one or two premature extrastimuli, this was only the case in 27% of Group B patients (p = 0.045). Group B patients required cardioversion of their induced arrhythmias more frequently than did Group C patients (50 versus 27%, p = 0.038). There were no differences in the proportion of patients with induced monomorphic ventricular tachycardia or in the coupling interval of the last extrastimulus that resulted in arrhythmia induction in the Group B and Group C patients.
Discussion
Self-terminating induced ventricular tachycardia in patients with coronary artery disease. This study demonstrates that in patients with a history of myocardial infarction or coronary artery disease, the induction of 210 beats of self-terminating ventricular tachycardia with a mean cycle length of 5250 ms reliably predicts the subsequent induction of sustained ventricular tachycardia when the stimulation protocol is continued. Furthermore, each patient's induced self-terminating and sustained ventricular tachycardias were remarkably similar in configuration and rate. In contrast, in patients without coronary artery disease in whom selfterminating ventricular tachycardia is induced, only 27% developed sustained ventricular tachycardia when the stimulation protocol was completed. Self-terminating ventricular tachycardia also predicted the induction of sustained ventricular tachycardia in patients with a history of clinical sustained ventricular arrhythmias, although the correlation was much weaker than that for coronary artery disease (p = 0.03 versus p < 0.0001). Clinical sustained ventricular arrhythmias may not be an independent predictor because all but one patient with such arrhythmias who had induction of both self-terminating and sustained ventricular tachycardias also had coronary artery disease. Thus, in patients with coronary artery disease, the induction of self-terminating ventricular tachycardia meeting these criteria appears to be equivalent to the induction of sustained ventricular tachycardia.
Clinical and electrophysiologic variables in the three patient groups. Clinically, Group B and Group C patients were very similar. It was expected that the Group B patients would have faster induced sustained ventricular tachycardia than Group C patients because, by definition, the former group had rapid induced self-terminating ventricular tachycardia. The balance between slow conduction and recovery of excitability is more tenuous in rapid reentrant arrhythmias, making self-terminating episodes more likely than in those patients with a slower tachycardia. The shorter ventricular tachycardia cycle length in Group B patients may reflect anatomically smaller circuits that require three premature extrastimuli for the development of sustained reentry. In contrast, the electrophysiologic and clinical variables in Group A and Group B patients were markedly different. One-third of the Group A patients (inducible rapid selfterminating ventricular tachycardia only) had a normal heart and a normal mean left ventricular ejection fraction, and the induction of self-terminating ventricular tachycardia required more aggressive stimulation. The induction of rapid self-terminating ventricular tachycardia with one or two premature extrastimuli appears to be predictive of subsequent sustained ventricular tachycardia induction because all patients in Group A had the tachycardia induced with three premature extrastimuli.
Multiple studies (1,3,10-13) have shown that selfterminating ventricular tachycardia is frequently induced in patients undergoing electrophysiologic studies who have coronary or structural heart disease. The frequency of induction of self-terminating ventricular tachycardia in the present investigation is not directly comparable with that in these earlier studies. Only patients whose induced arrhythmias met the rate and duration criteria were included in our investigation. Most Group C patients (sustained ventricular tachycardia only) had coronary artery disease, and many of them had episodes of induced self-terminating ventricular tachycardia that were <lo beats in duration or had a mean cycle length >250 ms.
Polymorphic ventricular tachycardia. The induction of monomorphic sustained ventricular tachycardia in patients with documented or suspected sustained ventricular arrhythmias is widely considered to be a highly specific finding (l-4). However, the clinical significance of induced selfterminating ventricular tachycardia, particularly when it is polymorphic, is controversial (l-3,10-12,19-22). In Group B, 45% of patients had induced self-terminating polymorphic ventricular tachycardia, and 90% of these patients had coronary artery disease. After further stimulation, all Group B patients developed sustained ventricular tachycardia, and 45% of these sustained arrhythmias were polymorphic. In the seven patients with induced polymorphic selfterminating ventricular tachycardia whose clinical arrhythmias were available for analysis, six had clinical arrhythmias that were demonstrated to be polymorphic, supporting the clinical relevance of induced polymorphic ventricular tachycardia in these patients. In addition, although degeneration to ventricular fibrillation eventually occurred in several patients, no patient had ventricular fibrillation as the initial induced arrhythmia.
Other investigations have also examined induced polymorphic self-terminating ventricular tachycardia. Brugada et al. (10) induced polymorphic self-terminating ventricular tachycardia (six or more beats) in 46% of patients who had neither clinical arrhythmias nor structural heart disease. Despite using an aggressive stimulation protocol, including up to four premature extrastimuli, they were unable to induce sustained polymorphic ventricular tachycardia in these patients. Similar to our results, they found that induced polymorphic sustained ventricular tachycardia appeared to be a meaningful response in that it was only induced in patients with clinical ventricular arrhythmias. Likewise, Morady et al. (19) , using three premature extrastimuli induced polymorphic self-terminating ventricular tachycardia (six or more beats) in 12% of patients without clinical ventricular arrhythmias. Sustained polymorphic ventricular tachycardia was not induced in any of their patients.
Buxton et al. (2) induced polymorphic self-terminating ventricular tachycardia (six or more beats) in 19% of patients without clinical ventricular arrhythmias and sustained polymorphic ventricular tachycardia in only 3% of their patients. These investigators also found that polymorphic selfterminating ventricular tachycardia was commonly induced in patients with clinical arrhythmias (it was induced in 18% of their patients with documented clinical monomorphic ventricular tachycardia). Mann et al. (12) were not able to induce sustained polymorphic ventricular tachycardia in any of 68 patients without clinical arrhythmias despite the use of up to four premature extrastimuli. We have extended these findings by demonstrating that, in patients with coronary artery disease and documented or suspected clinical arrhythmias, induced self-terminating ventricular tachycardia, regardless of its configuration. is a significant finding because it reliably predicts induction of sustained ventricular tachycardia. In contrast, this arrhythmia is not predictive in patients without coronary artery disease.
Limitations of study. We only examined self-terminating ventricular tachycardia that met the specific criteria of having a duration 210 beats and a cycle length 5250 ms. It is possible that other criteria might be as effective in determining a meaningful study end point. We only studied patients with known or suspected ventricular arrhythmias and, thus, our conclusions may not be applicable to patient groups without clinical arrhythmias. Lastly, a variety of definitions of polymorphic ventricular tachycardia were used in other studies (1,2,12). Our definition is similar to that of Torres et al. (13) and we believe it is a concise and reproducible definition.
Clinical implications.
We have found that, in patients with coronary artery disease and documented or suspected clinical arrhythmias, the induction of rapid self-determining ventricular tachycardia reliably predicts the subsequent induction of sustained ventricular tachycardia of similar rate and configuration. Thus, in patients with coronary artery disease, the induction of rapid self-terminating ventricular tachycardia appears to be a significant response and may be utilized as an electrophysiologic study end point. When sustained ventricular tachycardia was subsequently induced, it required cardioversion in 50% of the patients. The use of self-terminating ventricular tachycardia as an electrophysiologic study end point in patients with coronary artery disease will substantially reduce the need for cardioversion.
Although not directly addressed by this study, our findings may also have implications for drug efficacy trials. In the drug-free state, the induction of rapid self-terminating ventricular tachycardia meeting our criteria appears to be an electrophysiologic response similar to that of the induction of sustained ventricular tachycardia in patients with coronary artery disease. The relation between induced selfterminating ventricular tachycardia and sustained ventricular tachycardia after pharmacologic administration is not clear. However. the findings of this investigation raise the concern that the conversion of inducible sustained ventricular tachycardia to inducible rapid self-terminating ventricular tachycardia after antiarrhythmic drug administration may not represent a significant clinical improvement. This warrants further investigation. 
